Literature DB >> 30014206

Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics.

Zelma Faisal1,2, Beáta Lemli2,3,4, Dénes Szerencsés3, Sándor Kunsági-Máté2,3,4, Mónika Bálint5, Csaba Hetényi5, Mónika Kuzma6, Mátyás Mayer6, Miklós Poór7,8.   

Abstract

Zearalenone (ZEN) is a mycotoxin produced by Fusarium species. ZEN mainly appears in cereals and related foodstuffs, causing reproductive disorders in animals, due to its xenoestrogenic effects. The main reduced metabolites of ZEN are α-zearalenol (α-ZEL) and β-zearalenol (β-ZEL). Similarly to ZEN, ZELs can also activate estrogen receptors; moreover, α-ZEL is the most potent endocrine disruptor among these three compounds. Serum albumin is the most abundant plasma protein in the circulation; it affects the tissue distribution and elimination of several drugs and xenobiotics. Although ZEN binds to albumin with high affinity, albumin-binding of α-ZEL and β-ZEL has not been investigated. In this study, the complex formation of ZEN, α-ZEL, and β-ZEL with human (HSA), bovine (BSA), porcine (PSA), and rat serum albumins (RSA) was investigated by fluorescence spectroscopy, affinity chromatography, thermodynamic studies, and molecular modeling. Our main observations are as follows: (1) ZEN binds with higher affinity to albumins than α-ZEL and β-ZEL. (2) The low binding affinity of β-ZEL toward albumin may result from its different binding position or binding site. (3) The binding constants of the mycotoxin-albumin complexes significantly vary with the species. (4) From the thermodynamic point of view, the formation of ZEN-HSA and ZEN-RSA complexes are similar, while the formation of ZEN-BSA and ZEN-PSA complexes are markedly different. These results suggest that the toxicological relevance of ZEN-albumin and ZEL-albumin interactions may also be species-dependent.

Entities:  

Keywords:  Fluorescence spectroscopy; Serum albumin; Species-dependent alternations; Zearalenols; Zearalenone

Mesh:

Substances:

Year:  2018        PMID: 30014206     DOI: 10.1007/s12550-018-0321-6

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  30 in total

1.  Simultaneous determination of aflatoxin M1, ochratoxin A, zearalenone and α-zearalenol in milk by UHPLC-MS/MS.

Authors:  L C Huang; N Zheng; B Q Zheng; F Wen; J B Cheng; R W Han; X M Xu; S L Li; J Q Wang
Journal:  Food Chem       Date:  2013-09-18       Impact factor: 7.514

2.  Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model.

Authors:  Ferenc Zsila
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

3.  Interaction of zearalenone with bovine serum albumin as determined by fluorescence quenching.

Authors:  Liang Ma; Chris M Maragos; Yuhao Zhang
Journal:  Mycotoxin Res       Date:  2017-11-13       Impact factor: 3.833

4.  Thermodynamics of protein association reactions: forces contributing to stability.

Authors:  P D Ross; S Subramanian
Journal:  Biochemistry       Date:  1981-05-26       Impact factor: 3.162

5.  Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis.

Authors:  C Frizzell; D Ndossi; S Verhaegen; E Dahl; G Eriksen; M Sørlie; E Ropstad; M Muller; C T Elliott; L Connolly
Journal:  Toxicol Lett       Date:  2011-07-23       Impact factor: 4.372

6.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

Review 7.  Albumin-drug interaction and its clinical implication.

Authors:  Keishi Yamasaki; Victor Tuan Giam Chuang; Toru Maruyama; Masaki Otagiri
Journal:  Biochim Biophys Acta       Date:  2013-05-10

8.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

9.  Dose-response effects of estrogenic mycotoxins (zearalenone, alpha- and beta-zearalenol) on motility, hyperactivation and the acrosome reaction of stallion sperm.

Authors:  Angela Filannino; Tom A E Stout; Bart M Gadella; Edita Sostaric; Flavia Pizzi; Ben Colenbrander; Maria Elena Dell'Aquila; Fiorenza Minervini
Journal:  Reprod Biol Endocrinol       Date:  2011-10-05       Impact factor: 5.211

10.  Fumonisins, trichothecenes and zearalenone in cereals.

Authors:  Selma Yazar; Gülden Z Omurtag
Journal:  Int J Mol Sci       Date:  2008-10-31       Impact factor: 6.208

View more
  11 in total

1.  In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity.

Authors:  Erzsébet Pászti-Gere; Anna Szentkirályi-Tóth; Pál Szabó; Torsten Steinmetzer; Eszter Fliszár-Nyúl; Miklós Poór
Journal:  Biomed Pharmacother       Date:  2022-05-17       Impact factor: 7.419

2.  Fluorescence Spectroscopic Investigation of Competitive Interactions between Quercetin and Aflatoxin B₁ for Binding to Human Serum Albumin.

Authors:  Hongxia Tan; Lu Chen; Liang Ma; Shuang Liu; Hongyuan Zhou; Yuhao Zhang; Ting Guo; Wei Liu; Hongjie Dai; Yong Yu
Journal:  Toxins (Basel)       Date:  2019-04-09       Impact factor: 4.546

3.  Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo.

Authors:  Sebastian Fruhauf; Barbara Novak; Veronika Nagl; Matthias Hackl; Doris Hartinger; Valentina Rainer; Silvia Labudová; Gerhard Adam; Markus Aleschko; Wulf-Dieter Moll; Michaela Thamhesl; Bertrand Grenier
Journal:  Toxins (Basel)       Date:  2019-08-20       Impact factor: 4.546

4.  Interaction of the Emerging Mycotoxins Beauvericin, Cyclopiazonic Acid, and Sterigmatocystin with Human Serum Albumin.

Authors:  Eszter Fliszár-Nyúl; Zelma Faisal; Renáta Skaper; Beáta Lemli; Bayarsaikhan Bayartsetseg; Csaba Hetényi; Patrik Gömbös; András Szabó; Miklós Poór
Journal:  Biomolecules       Date:  2022-08-11

5.  In Vitro Evaluation of the Individual and Combined Cytotoxic and Estrogenic Effects of Zearalenone, Its Reduced Metabolites, Alternariol, and Genistein.

Authors:  Adrienn Balázs; Zelma Faisal; Rita Csepregi; Tamás Kőszegi; Balázs Kriszt; István Szabó; Miklós Poór
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

6.  Probing the Interactions of Ochratoxin B, Ochratoxin C, Patulin, Deoxynivalenol, and T-2 Toxin with Human Serum Albumin.

Authors:  Zelma Faisal; Virág Vörös; Eszter Fliszár-Nyúl; Beáta Lemli; Sándor Kunsági-Máté; Rita Csepregi; Tamás Kőszegi; Ferenc Zsila; Miklós Poór
Journal:  Toxins (Basel)       Date:  2020-06-13       Impact factor: 4.546

Review 7.  Zearalenone (ZEN) in Livestock and Poultry: Dose, Toxicokinetics, Toxicity and Estrogenicity.

Authors:  Jundi Liu; Todd Applegate
Journal:  Toxins (Basel)       Date:  2020-06-07       Impact factor: 4.546

8.  Interaction of 2'R-ochratoxin A with Serum Albumins: Binding Site, Effects of Site Markers, Thermodynamics, Species Differences of Albumin-binding, and Influence of Albumin on Its Toxicity in MDCK Cells.

Authors:  Zelma Faisal; Diána Derdák; Beáta Lemli; Sándor Kunsági-Máté; Mónika Bálint; Csaba Hetényi; Rita Csepregi; Tamás Kőszegi; Franziska Sueck; Benedikt Cramer; Hans-Ulrich Humpf; Miklós Poór
Journal:  Toxins (Basel)       Date:  2018-09-01       Impact factor: 4.546

9.  Testing the Pharmacokinetic Interactions of 24 Colonic Flavonoid Metabolites with Human Serum Albumin and Cytochrome P450 Enzymes.

Authors:  Violetta Mohos; Eszter Fliszár-Nyúl; Beáta Lemli; Balázs Zoltán Zsidó; Csaba Hetényi; Přemysl Mladěnka; Pavel Horký; Milan Pour; Miklós Poór
Journal:  Biomolecules       Date:  2020-03-06

10.  Interactions of zearalanone, α-zearalanol, β-zearalanol, zearalenone-14-sulfate, and zearalenone-14-glucoside with serum albumin.

Authors:  Zelma Faisal; Virág Vörös; Eszter Fliszár-Nyúl; Beáta Lemli; Sándor Kunsági-Máté; Miklós Poór
Journal:  Mycotoxin Res       Date:  2020-08-01       Impact factor: 3.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.